Sofwave Before and After: What Results Look Like

Start with the cleared list, because it is the only set of claims the FDA text stands behind.

The current 510(k) clearance, K250146, dated April 18, 2025, describes Sofwave as a non-invasive treatment to improve facial lines and wrinkles, lift the eyebrow, and lift lax submental — beneath the chin — and neck tissue in people aged 22 and older, with short-term improvement in the appearance of cellulite, acne scars and skin laxity on the upper arms also cleared.

Those indications accumulated over six years.

The first US clearance, K191421, came on September 9, 2019 — under the name "Sofacia System" — for improving facial lines and wrinkles in people 22 and older, and the brow, neck, cellulite, acne-scar and upper-arm uses were added through later 510(k)s between 2021 and 2025.

What the device does, briefly: FDA's 510(k) summary describes an applicator of ultrasonic transducers emitting at 10–12 MHz with an active cooling element, heating the dermis to create controlled, isolated areas of thermal damage.

Sofwave says its SUPERB technology uses 7 parallel beam transducers, with the thermal effect localized 0.5 to 2 mm deep, centered at 1.5 mm in the mid-dermis, heating the dermis to about 60–70°C — those depth and temperature figures are the manufacturer's own.

What none of that gives you is a size of change.

The clearance names what the device is indicated to treat; it does not quantify the result, and we could not find verified improvement rates or a results timeline for Sofwave in the sources we checked.

A before-and-after photo is one case at one time point, not a range you can expect to land in.

Sofwave builds its own materials around a single visit: the company says a treatment session typically takes 30–45 minutes, and its pricing guidance describes the typical course as one session.

Session count is also a main driver of price, so a practice recommending more than one visit is quoting you for more than one.

Even the maker's own gallery complicates the one-session story: some of Sofwave's before-and-after photos are labeled "After 2 treatments." Between that and the absence of a tested session count in the sources we checked, the practical answer is to ask each practice how many sessions it recommends for your areas, and why it recommends them.

Timing is the same honest story.

We could not confirm a "results by week" timeline for Sofwave from the sources we checked; the only dated results we can point to are photo captions in Sofwave's gallery, which run from 4–6 weeks after treatment to 3 months and up to 10 months.

A photo date is a record of one case, not a schedule for yours.

For session counts, pricing structure and duration questions, our Sofwave guide goes deeper.

Here is the area-by-area map: what the clearance covers for each concern you might be searching, and what Sofwave's own gallery shows.

• Face — lines and wrinkles. Improving facial lines and wrinkles is the original cleared indication, first cleared in 2019 and carried through to the current clearance.
• Eyes — the brow. The cleared wording is lifting the eyebrow. That is the only eye-area use in the cleared indications, so any other eye-area promise you read goes beyond them.
• Jawline, chin and neck. The cleared wording is lifting lax submental tissue — the area beneath the chin — and neck tissue. The jawline itself is not named in the clearance, so if you are searching for a "sofwave before and after jawline" result, that submental/neck wording is the closest cleared use — ask what area a "jawline" photo actually treated. Sofwave's gallery includes a neck-procedure photo taken 10 months after treatment.
• Cellulite, acne scars and upper arms. These sit under a narrower cleared claim: short-term improvement in the appearance of cellulite and acne scars, and short-term improvement in skin laxity on the upper arms. In the clearance's own wording, both "short-term" and "appearance" are doing real work.

Anything outside this list — a different body area, a different claim — is not a cleared use of the device, whatever a gallery photo implies.

And the cleared wording names the use, not the size of the change: our research found no verified improvement rate for Sofwave in any of these areas.

Candidacy is the first variable.

Sofwave lists situations where its treatment should not be used, and anyone those items describe is not a candidate for the treatment on the maker's own list.

The maker's list includes pregnancy or breastfeeding (or giving birth less than 3 months ago), a pacemaker or other electronic implant in the area, metal stents or implants in the face, open wounds, severe or cystic acne, active infection, isotretinoin or another retinoid within the past 6 months, and anti-platelet, anti-coagulant or psychiatric drugs within the past 2 weeks.

Filler gets its own line in the same safety information: treatment directly over dermal filler is not recommended.

The cleared areas include the brow and the tissue beneath the chin and on the neck, so that one line changes who can be treated where — which is why a practice needs to know about any filler before a session is booked.

Skin type is a claim to read carefully.

Sofwave's patient page says the device is "FDA-cleared to treat all skin types"; the cleared indications text does not mention skin types at all, so that statement is the company's own claim, not an FDA determination.

How your skin handles heat-based treatment is a question for a licensed provider who has examined your skin.

None of this predicts an individual outcome.

It is why two before-and-after photos of the same device can legitimately look different, and why the consultation — where a licensed provider weighs your skin, your history and your medications — is where your own variables get counted.

A before-and-after gallery is marketing, whether it is the maker's or the practice's, so it helps to know the rules those photos sit under and the details that make one photo comparable to another.

Consent comes first.

Under HIPAA, full-face photographs and comparable images are identifiers that must be removed for health information to count as de-identified, so before-and-after photos taken by a covered provider are protected health information — and HIPAA requires a covered entity to obtain a patient's written authorization before using photos like these for marketing.

So a gallery built on a covered provider's patient photos should rest on written, documented consent.

Then the labels.

Manufacturer before-and-afters are often labeled with the number of treatments and the time point, and Sofwave's own gallery runs from photos taken 4–6 weeks after treatment to 3 months and up to 10 months, with some labeled "After 2 treatments." Two photos at different time points or session counts are not a comparison — match those first, then check the rest:

One framing to keep: even an honest, consented, unretouched photo shows what happened for one person at one time point.

It cannot tell you the range of what generally happens, and it cannot show your result.

That is not a reason to ignore galleries — it is a reason to read them as claims that need context, and to ask each practice how it takes and labels its photos.